Pinealon

II. What is this compound?

Pinealon (Glu-Asp-Arg, or EDR) weighs about 418 daltons — small enough to reach spots that bigger peptides may miss. It is a peptide bioregulator: a short chain of amino acids that may touch cell DNA and change gene use. The chain is L-glutamic acid, L-aspartic acid, and L-arginine. It grew out of the St. Petersburg Institute of Bioregulation and Gerontology [2] PMID: 21978084 .

The bioregulator idea sets pinealon apart from peptides that use receptors. Khavinson's group held that peptides of 2 to 4 amino acids may enter the cell core and bind gene start sites. That places pinealon with epitalon Epitalon tetrapeptide Pineal peptide studied for telomerase activation and longevity (Ala-Glu-Asp-Gly) and vesugen, though each aims at different cells.

In tests, pinealon was given by shot in the belly in animals. Its tiny size hints that it may reach the brain well, though no human tests have run — which is why the section below leans on what is proposed, not shown. All data come from animal work and small Russian patient notes.

III. How it works

Pinealon's proposed route looks odd next to other peptide work: direct gene use control. Most peptides use receptors on the cell wall. Pinealon is hypothesized to enter the cell core and bind gene start sites, changing how survival genes work [3] PMID: 33396470 .

The best-shown effect is lowering ROS. In cell tests, pinealon cut ROS levels as the dose rose. Neurons under stress that got pinealon had far less ROS and less cell death than the rest. This effect came at levels well below what carnosine needs for the same care [4] PMID: 21978084 .

A second path runs through cell death control. Work shows pinealon lowers caspase-3 — a key enzyme in cell death — and the p53 tumor guard. By dropping caspase-3 use, pinealon may slow nerve cell loss under stress. The p53 link hints at a wider role in cell growth than plain ROS work alone [5] PMID: 33396470 .

Third, work points to mitochondria support: tests on cytochrome C oxidase, a key link in the cell's power chain, hint that pinealon may shift how well mitochondria work — linking it to the wider field of power-chain test tools [6] PMID: 21978084 . These routes only matter once they show up in live animals — which the next section covers.

• Suppression of reactive oxygen species (ROS) accumulation in neurons
  PMID 21978084
• Gene expression modulation via direct DNA interaction in brain and pineal tissue
  PMID 33396470
• Regulation of caspase-3 and p53 to reduce neuronal apoptosis
  PMID 33396470
• Modulation of cytochrome C oxidase activity in mitochondria
  PMID 21978084

IV. Research Findings

The top preclinical find is nerve cell care under stress. In rats with prenatal high homocysteine — a state that harms baby nerves via NMDA receptors and ROS build-up — shots for pregnant dams saved baby rats from mind loss. The treated pups did better on the Morris water maze and took more peroxide stress [7] PMID: 21978084 . In a brain-growth test, care that spans to the next turn is a strong sight.

Mind care showed up more: pinealon kept rats able to learn after a set case of diabetes — a state known to hurt the memory center via stress and swelling — a fit with the proposed gene route in brain cells [8] PMID: 21978084 .

Aging-care signs make the third leg — and the closest thing to human work. One note study in older patients with organic brain syndrome said pinealon with vesugen upped marks of cell age and brain care, hinting at cell growth and nerve care that may slow the pace of cell age. With no random pick and a small set, those views can carry less weight [9] PMID: 26390612 .

Last, cell strength goes past the nerves: cell tests on skin cells from old donors found pinealon raised cell life and new cell growth, hinting at care that reaches past the brain [10] PMID: 22803085 .

• neuroprotection preclinical
  PMID 21978084PMID 33396470
• cognitive-function preclinical
  PMID 21978084
• anti-aging preclinical
  PMID 26390612
• cellular-resilience preclinical
  PMID 21978084PMID 22803085

V. Dosage Context Explained

Pinealon dose notes are few, and all are mouse-scale. The most cited study used 10 μg/kg/day by shot in the belly for 5 days in a rat test of high homocysteine before birth — a pick made to probe nerve care in one growth phase [11] PMID: 21978084 .

In the note study with older patients, pinealon was given with vesugen, though dose notes were thin in the English abstract [12] PMID: 26390612 . The Russian set calls pinealon a "cytogen" — short cell-tune-up runs. Nose drops have been floated for brain work, as the tiny size may let it use the smell route to the brain, but no set nose-drop plan has hit peer work.

Use each figure here as a test-side mark, not a human cue. No agency has set human dose rules, and mouse shot doses do not move across kinds or routes — which is why the thin safety note matters next.

• Administration Routes

  intraperitoneal

  Range

  10 μg/kg/day for 5 days

  rat model of prenatal hyperhomocysteinemia

  PMID 21978084

VI. Side Effects: Research Context

Pinealon's written safety note is striking for its small size. The tests to date show no harm at the doses used, which points to a wide gap in animals — but that quiet stem from the small scope of the work, not full toxin tests. No full toxin runs, dose-up trials, or long-term cancer checks have run.

The proposed direct-DNA route raises mind-wander risks of wrong gene change, though no sign of gene harm has shown. One lead-in flows from the plan: active cancer. Any tool that shifts gene use and cell life paths calls for care in cancer cases — more so with the seen p53 shift, as p53 sits at the core of tumor guard [13] PMID: 33396470 .

With no set human watch data at hand, moving risk from animal work to people stays a guess — a gap to hold next to the law note below.

• none documented in preclinical models

VII. Frequently Asked Questions